2012
DOI: 10.1001/archneurol.2012.1541
|View full text |Cite
|
Sign up to set email alerts
|

Association of Shorter Leukocyte Telomere Repeat Length With Dementia and Mortality

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

15
118
1
1

Year Published

2014
2014
2017
2017

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 157 publications
(137 citation statements)
references
References 40 publications
15
118
1
1
Order By: Relevance
“…Telomere measurements were performed as previously described (Honig et al 2012). Coded DNA samples were processed by laboratory personnel, masked to participant characteristics including dietary information.…”
Section: Telomere Measurementmentioning
confidence: 99%
See 1 more Smart Citation
“…Telomere measurements were performed as previously described (Honig et al 2012). Coded DNA samples were processed by laboratory personnel, masked to participant characteristics including dietary information.…”
Section: Telomere Measurementmentioning
confidence: 99%
“…Some cells, such as germline cells, have greater ability to preserve telomere length through the enzymatic activity known as telomerase. Leukocyte telomere length (LTL) has been proposed to be a marker for biological aging, and shortened LTL has been related with higher allcause mortality (Honig et al 2012) as well as a variety of age-related conditions such as cardiovascular disease (Estruch et al 2013;Mainous et al 2010;Perez-Rivera et al 2014), diabetes (Zhao et al 2013), and dementia (Honig et al 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Mutations that decrease telomerase and cause short telomeres in humans lead to a spectrum of premature-onset diseases and conditions collectively termed "telomere syndromes," which share many features of the common diseases of aging in the human population (Armanios and Blackburn 2012). Multiple independent studies have found impaired human telomeric DNA length maintenance to be associated with a wide range of diseases and for several age-related diseases to predict future risks and outcomes including mortality (Von Zglinicki et al 2000;Samani et al 2001;Cawthon et al 2003;Panossian et al 2003;Valdes et al 2005;Bischoff et al 2006;Harris et al 2006;MartinRuiz et al 2006;Bakaysa et al 2007;Brouilette et al 2007;Fitzpatrick et al 2007Fitzpatrick et al , 2011Aubert and Lansdorp 2008;Farzaneh-Far et al 2008;Kimura et al 2008;Epel et al 2009;Njajou et al 2009;Astrup et al 2010;Codd et al 2010Codd et al , 2013Salpea et al 2010;Willeit et al 2010a,b;Zee et al 2010;Strandberg et al 2011;Wentzensen et al 2011;Yaffe et al 2011;Honig et al 2012;Lee et al 2012;Weischer et al 2012;Bojesen 2013;Muezzinler et al 2013;Gardner et al 2014;Haycock et al 2014;Walsh et al 2014).…”
mentioning
confidence: 99%
“…A recent study incorporating data from the National Health and Nutrition Examination Survey (NHANES) 1999-2002, a large, nationally representative, ethnically and socioeconomically diverse sample, reported that sex, race-ethnicity, and socioeconomic status (SES) moderated the associations between TL and mortality in older individuals (Needham et al 2012). However, while some human cohort studies have found shorter PBMC TL or LTL is associated with increased mortality (Cawthon et al 2003;Martin-Ruiz et al 2006;Bakaysa et al 2007;Farzaneh-Far et al 2008;Kimura et al 2008;Epel et al 2009;Astrup et al 2010;Willeit et al 2010b;Fitzpatrick et al 2011;Honig et al 2012;Lee et al 2012;Weischer et al 2012), others have not (Bischoff et al 2006;Harris et al 2006;Njajou et al 2009;Strandberg et al 2011). These inconsistencies in the literature may be due to differences in study cohorts, sample sizes, assay methods, and other methodological differences (Bojesen 2013).…”
mentioning
confidence: 99%
“…Hayflick (HAYFLICK, 1965) (HONIG et al, 2006(HONIG et al, , 2012KOTA et al, 2015), incluindo a doença de Alzheimer (DA) (LIU et al, 2016). …”
Section: Encurtamento Teloméricounclassified